Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
R275210-1mg | 1mg | In stock | $21.90 | |
R275210-5mg | 5mg | In stock | $90.90 | |
R275210-25mg | 25mg | In stock | $184.90 | |
R275210-50mg | 50mg | In stock | $276.90 |
Selective cyclin-dependent kinase (Cdk1) inhibitor
Synonyms | (5Z)-5-(6-Quinolinylmethylene)-2-[(2-thienylmethyl)amino)-4(5H)-thiazolone |
---|---|
Specifications & Purity | 98% |
Source | Synthetic |
Storage Temp | Store at -20°C,Desiccated |
Shipped In | Dry ice |
Grade | Moligand™ |
Action Type | INHIBITOR |
Mechanism of action | Inhibitor of cyclin dependent kinase 1;Inhibitor of cyclin dependent kinase 2;Inhibitor of cyclin dependent kinase 5 |
Product Description | Store at -20°C. Store under desiccating conditions. The product can be stored for up to 12 months. |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | (5Z)-5-(quinolin-6-ylmethylidene)-2-(thiophen-2-ylmethylimino)-1,3-thiazolidin-4-one |
---|---|
INCHI | InChI=1S/C18H13N3OS2/c22-17-16(24-18(21-17)20-11-14-4-2-8-23-14)10-12-5-6-15-13(9-12)3-1-7-19-15/h1-10H,11H2,(H,20,21,22)/b16-10- |
InChi Key | XOLMRFUGOINFDQ-YBEGLDIGSA-N |
Canonical SMILES | C1=CC2=C(C=CC(=C2)C=C3C(=O)NC(=NCC4=CC=CS4)S3)N=C1 |
Isomeric SMILES | C1=CC2=C(C=CC(=C2)/C=C\3/C(=O)NC(=NCC4=CC=CS4)S3)N=C1 |
PubChem CID | 135400873 |
Molecular Weight | 351.44 |
PubChem CID | 136240579 |
---|---|
CAS Registry No. | 872573-93-8 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
G2208332 | Certificate of Analysis | Apr 17, 2023 | R275210 |
G2208333 | Certificate of Analysis | Apr 17, 2023 | R275210 |
G2208286 | Certificate of Analysis | Apr 17, 2023 | R275210 |
G2208235 | Certificate of Analysis | Apr 17, 2023 | R275210 |
Solubility | insoluble in EtOH; insoluble in H2O; ≥4.39 mg/mL in DMSO |
---|---|
Sensitivity | Heat Sensitive |
1. Vassilev LT, Tovar C, Chen S, Knezevic D, Zhao X, Sun H, Heimbrook DC, Chen L. (2006) Selective small-molecule inhibitor reveals critical mitotic functions of human CDK1.. Proc Natl Acad Sci USA, 103 (28): (10660-5). [PMID:16818887] |
2. Jorda R, Hendrychová D, Voller J, Řezníčková E, Gucký T, Kryštof V. (2018) How Selective Are Pharmacological Inhibitors of Cell-Cycle-Regulating Cyclin-Dependent Kinases?. J Med Chem, 61 (20): (9105-9120). [PMID:30234987] |
3. Matsubara S et al.. (2020) Fractionation of Ovarian Follicles and in vitro Oocyte Maturation and Ovulation Assay of Ciona intestinalis Type A.. Bio Protoc, 10 (7): (e3577). [PMID:33659547] |
4. Huang CR et al.. (2021) Host CDK-1 and formin mediate microvillar effacement induced by enterohemorrhagic Escherichia coli.. Nat Commun, 12 (90). [PMID:33397943] |
5. Mukherjee A et al.. (2020) Nuclear plasticity increases susceptibility to damage during confined migration.. PLoS Comput Biol, 16 (10): (e1008300). [PMID:33035221] |
6. Matsubara S et al.. (2019) The regulation of oocyte maturation and ovulation in the closest sister group of vertebrates.. Elife, 8 [PMID:31573508] |